389 related articles for article (PubMed ID: 35990688)
1. Mesenchymal stem/stromal cells in the pathogenesis and regenerative therapy of inflammatory bowel diseases.
Che Z; Ye Z; Zhang X; Lin B; Yang W; Liang Y; Zeng J
Front Immunol; 2022; 13():952071. PubMed ID: 35990688
[TBL] [Abstract][Full Text] [Related]
2. Potential methods for improving the efficacy of mesenchymal stem cells in the treatment of inflammatory bowel diseases.
Zhang X; Wang S; Ding X; Guo J; Tian Z
Scand J Immunol; 2020 Sep; 92(3):e12897. PubMed ID: 32443180
[TBL] [Abstract][Full Text] [Related]
3. Cytokine Mixtures Mimicking the Local Milieu in Patients with Inflammatory Bowel Disease Impact Phenotype and Function of Mesenchymal Stromal Cells.
Barnhoorn MC; van der Meulen-de Jong AE; Schrama ECLM; Plug LG; Verspaget HW; Fibbe WE; van Pel M; Hawinkels LJAC; Schepers K
Stem Cells Transl Med; 2022 Sep; 11(9):932-945. PubMed ID: 35984079
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and Safety of Mesenchymal Stem/Stromal Cell Therapy for Inflammatory Bowel Diseases: An Up-to-Date Systematic Review.
Ko JZ; Johnson S; Dave M
Biomolecules; 2021 Jan; 11(1):. PubMed ID: 33440772
[TBL] [Abstract][Full Text] [Related]
5. Molecular and Cellular Mechanisms Involved in Mesenchymal Stem Cell-Based Therapy of Inflammatory Bowel Diseases.
Markovic BS; Kanjevac T; Harrell CR; Gazdic M; Fellabaum C; Arsenijevic N; Volarevic V
Stem Cell Rev Rep; 2018 Apr; 14(2):153-165. PubMed ID: 29177796
[TBL] [Abstract][Full Text] [Related]
6. Human cord blood-derived platelet lysate enhances the therapeutic activity of adipose-derived mesenchymal stromal cells isolated from Crohn's disease patients in a mouse model of colitis.
Forte D; Ciciarello M; Valerii MC; De Fazio L; Cavazza E; Giordano R; Parazzi V; Lazzari L; Laureti S; Rizzello F; Cavo M; Curti A; Lemoli RM; Spisni E; Catani L
Stem Cell Res Ther; 2015 Sep; 6(1):170. PubMed ID: 26353774
[TBL] [Abstract][Full Text] [Related]
7. Review article: mesenchymal stromal cell therapy for inflammatory bowel diseases.
Grégoire C; Lechanteur C; Briquet A; Baudoux É; Baron F; Louis E; Beguin Y
Aliment Pharmacol Ther; 2017 Jan; 45(2):205-221. PubMed ID: 27878827
[TBL] [Abstract][Full Text] [Related]
8. Perspectives of the International Society for Cell & Gene Therapy Gastrointestinal Scientific Committee on the Intravenous Use of Mesenchymal Stromal Cells in Inflammatory Bowel Disease (PeMeGi).
Ciccocioppo R; Baumgart DC; Dos Santos CC; Galipeau J; Klersy C; Orlando G
Cytotherapy; 2019 Aug; 21(8):824-839. PubMed ID: 31201092
[TBL] [Abstract][Full Text] [Related]
9. Impairment of Tissue-Resident Mesenchymal Stem Cells in Chronic Ulcerative Colitis and Crohn's Disease.
Grim C; Noble R; Uribe G; Khanipov K; Johnson P; Koltun WA; Watts T; Fofanov Y; Yochum GS; Powell DW; Beswick EJ; Pinchuk IV
J Crohns Colitis; 2021 Aug; 15(8):1362-1375. PubMed ID: 33506258
[TBL] [Abstract][Full Text] [Related]
10. Mesenchymal stromal cells and chronic inflammatory bowel disease.
Algeri M; Conforti A; Pitisci A; Starc N; Tomao L; Bernardo ME; Locatelli F
Immunol Lett; 2015 Dec; 168(2):191-200. PubMed ID: 26170204
[TBL] [Abstract][Full Text] [Related]
11. Human mesenchymal stem cell therapy in the management of luminal and perianal fistulizing Crohn's disease - review of pathomechanism and existing clinical data.
Bor R; Fábián A; Farkas K; Molnár T; Szepes Z
Expert Opin Biol Ther; 2018 Jul; 18(7):737-745. PubMed ID: 29939815
[TBL] [Abstract][Full Text] [Related]
12. Characterization of Intestinal Mesenchymal Stromal Cells From Patients With Inflammatory Bowel Disease for Autologous Cell Therapy.
Anbazhagan M; Geem D; Venkateswaran S; Pelia R; Kolachala VL; Dodd A; Maddipatla SC; Cutler DJ; Matthews JD; Chinnadurai R; Kugathasan S
Stem Cells Transl Med; 2023 Mar; 12(2):112-122. PubMed ID: 36869704
[TBL] [Abstract][Full Text] [Related]
13. [Therapy progression in surgery of inflammatory bowel diseases].
Zuo S; Wang X; Liu YC; Wang PY
Zhonghua Wei Chang Wai Ke Za Zhi; 2012 Aug; 15(8):872-6. PubMed ID: 22941697
[TBL] [Abstract][Full Text] [Related]
14. miRNA Molecules-Late Breaking Treatment for Inflammatory Bowel Diseases?
Aggeletopoulou I; Mouzaki A; Thomopoulos K; Triantos C
Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768556
[TBL] [Abstract][Full Text] [Related]
15. Interferon alpha (IFN alpha 2a) therapy for herpes virus-associated inflammatory bowel disease (ulcerative colitis and Crohn's disease).
Ruther U; Nunnensiek C; Muller HA; Bader H; May U; Jipp P
Hepatogastroenterology; 1998; 45(21):691-9. PubMed ID: 9684118
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic Potential of Secreted Molecules Derived from Human Amniotic Fluid Mesenchymal Stem/Stroma Cells in a Mice Model of Colitis.
Legaki E; Roubelakis MG; Theodoropoulos GE; Lazaris A; Kollia A; Karamanolis G; Marinos E; Gazouli M
Stem Cell Rev Rep; 2016 Oct; 12(5):604-612. PubMed ID: 27503204
[TBL] [Abstract][Full Text] [Related]
17. Mesenchymal Stem Cell as a Potential Therapeutic for Inflammatory Bowel Disease- Myth or Reality?
Adak S; Mukherjee S; Sen D
Curr Stem Cell Res Ther; 2017; 12(8):644-657. PubMed ID: 28914206
[TBL] [Abstract][Full Text] [Related]
18. Therapy with stem cells in inflammatory bowel disease.
Martínez-Montiel Mdel P; Gómez-Gómez GJ; Flores AI
World J Gastroenterol; 2014 Feb; 20(5):1211-27. PubMed ID: 24574796
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological modulation of P2X4 in inflammatory bowel diseases: the way towards novel therapeutics?
D'Antongiovanni V; Pellegrini C; Fornai M; Nemeth ZH; Haskó G; Antonioli L
J Drug Target; 2023 Aug; 31(7):693-699. PubMed ID: 37474908
[TBL] [Abstract][Full Text] [Related]
20. Treat-to-Target in Inflammatory Bowel Diseases, What Is the Target and How Do We Treat?
Agrawal M; Colombel JF
Gastrointest Endosc Clin N Am; 2019 Jul; 29(3):421-436. PubMed ID: 31078245
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
